C
Cheng Li
Researcher at Peking University
Publications - 238
Citations - 49764
Cheng Li is an academic researcher from Peking University. The author has contributed to research in topics: Gene & Medicine. The author has an hindex of 63, co-authored 200 publications receiving 42539 citations. Previous affiliations of Cheng Li include University of California, Los Angeles & Tongji University.
Papers
More filters
Journal ArticleDOI
Growth arrest, apoptosis, and telomere shortening of Barrett’s-associated adenocarcinoma cells by a telomerase inhibitor
TL;DR: It is concluded that telomerase inhibition by PPA induces cell growth arrest in BEAC cells and demonstrates the potential of telomersase inhibitors in chemoprevention and treatment of Barrett's-associated esophageal adenocarcinoma.
Journal ArticleDOI
Nuclear actin regulates inducible transcription by enhancing RNA polymerase II clustering
Mian Wei,Xiaoying Fan,Miao Ding,Ruifeng Li,Shipeng Shao,Yingping Hou,Shaoshuai Meng,Fuchou Tang,Cheng Li,Yujie Sun +9 more
TL;DR: This work unveils that nuclear actin promotes the formation of transcription factory on inducible genes, acting as a general mechanism underlying the rapid response to environmental cues.
Journal ArticleDOI
Two-round coamplification at lower denaturation temperature-PCR (COLD-PCR)-based sanger sequencing identifies a novel spectrum of low-level mutations in lung adenocarcinoma.
TL;DR: The ability to identify and sequence low‐level mutations in the absence of elaborate microdissection, via COLD‐PCR‐based Sanger sequencing, provides a platform for accurate mutation profiling in clinical specimens and the use of TP53 as a prognostic/predictive biomarker, evaluation of cancer risk, recurrence, and further understanding of cancer biology.
Journal ArticleDOI
NF1 Inactivation in Adult Acute Myelogenous Leukemia
Brian Parkin,Peter Ouillette,Yin Wang,Yan Liu,Whitney Wright,Diane Roulston,Anjali A. Purkayastha,Amanda Dressel,Judith E. Karp,Paula L. Bockenstedt,Ammar Al-Zoubi,Moshe Talpaz,Lisa Kujawski,Yang Liu,Kerby Shedden,Sajid Shakhan,Cheng Li,Harry P. Erba,Sami N. Malek +18 more
TL;DR: NF1 null states are present in 7 of 95 (7%) of adult AML and delineate a disease subset that could be preferentially targeted by Ras or mammalian target of rapamycin–directed therapeutics.
Journal ArticleDOI
YAP suppresses lung squamous cell carcinoma progression via deregulation of the DNP63-GPX2 axis and ros accumulation
Hsin-Yi Huang,Wenjing Zhang,Yafang Pan,Yijun Gao,Lei Deng,Fuming Li,Fei Li,Xueyan Ma,Shenda Hou,Jing Xu,Peixue Li,Xiaoxun Li,Guohong Hu,Cheng Li,Haiquan Chen,Lei Zhang,Hongbin Ji +16 more
TL;DR: In patient-derived xenograft models, digitoxin treatment efficiently inhibited lung SCC progression in correlation with reduced expression of YAP, highlighting a novel tumor-suppressor function of Y AP via downregulation of GPX2 and ROS accumulation.